Bio-signal Telemonitoring Using Electronic Textiles in a Pediatric Population

July 6, 2023 updated by: Aamir Jeewa
There is a need for developing reliable and convenient technologies for telemonitoring of physiological signals such as respiration, cardiac function, and activity level in children and especially for those with heart disease. Changing symptomatology causes heart failure patients to seek medical attention in order to be assessed and potentially have medication adjusted or additional testing being undertaken. These frequent clinical encounters affect the quality of life of these children and their parents, as well as being costly for the health care system. A textile based technology for telemonitoring application that is comfortable and accurate in its data collection can help to provide real time information on physiologic parameters. The primary research objective is to determine the feasibility and validity of a textile-enabled sensor system in measuring physiologic variables, or "biological signals", related to cardiopulmonary function in children. The study will include 10 patients with heart failure, and 10 healthy controls.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5G1X8
        • The Hospital for Sick Children

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria

  1. Healthy children participants (i.e. without CHD or HF) aged between 10 to 18 years with normal electrocardiograms and normal echocardiograms (i.e. screens for familial cardiomyopathy).

    OR

  2. Patients aged between 10 and 18 years with diagnosed congenital heart disease or cardiomyopathies referred to pediatric cardiology ambulatory clinic at SickKids.

Exclusion Criteria

  1. In-hospital patients.
  2. Patients too ill to participate or perform any activity.
  3. Patients with Fontan/single ventricle physiology circulation.
  4. Children who are less than 6 months post op from a cardiac surgery as they will have concerns from an activity and wound care standpoint.
  5. Participants with known allergies to adhesives (as reported by family).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SKIIN Textile Device in children with healthy hearts
The Myant SKIIN Device will be worn by study participants while they lay down, sit, stand, exercise and cool-down.
  1. Supine position: Participant lays on a bed on their back for 5 minutes
  2. Sitting position: Participant sits on a chair for 5 minutes
  3. Standing position: Participant stands for 5 minutes.
  4. Exercise measurement: treadmill exercise test - the protocol entails increases of 0.5 mph every minute with zero change in the incline. Starting point would 1.5 mph. The test will be interrupted if the target heart rate of 190 beats per minute is reached or if symptoms and/or arrhythmias and ST depression would be observed. Patient will be monitor during recovery for 5 minutes.
  5. Cool-down: Participants cool-down for 5 minutes
Experimental: SKIIN Textile Device in children with heart failure
The Myant SKIIN Device will be worn by study participants while they lay down, sit, stand, exercise and cool-down
  1. Supine position: Participant lays on a bed on their back for 5 minutes
  2. Sitting position: Participant sits on a chair for 5 minutes
  3. Standing position: Participant stands for 5 minutes.
  4. Exercise measurement: treadmill exercise test - the protocol entails increases of 0.5 mph every minute with zero change in the incline. Starting point would 1.5 mph. The test will be interrupted if the target heart rate of 190 beats per minute is reached or if symptoms and/or arrhythmias and ST depression would be observed. Patient will be monitor during recovery for 5 minutes.
  5. Cool-down: Participants cool-down for 5 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Validate the heart rate measurements obtained using the SKIIN Textile in children with and without heart disease.
Time Frame: 40 minutes
Validate the heart rate measurements obtained using the SKIIN Textile in children with and without heart disease compared to the measurements obtained by the Grael 4K PSG
40 minutes
Validate the respiratory rate measurements obtained using the SKIIN Textile in children with and without heart disease.
Time Frame: 40 minutes
Validate the respiratory rate measurements obtained using the SKIIN Textile in children with and without heart disease compared to the measurements obtained by the Grael 4K PSG.
40 minutes
Validate the pulse oximetry measurements obtained using the SKIIN Textile in children with and without heart disease.
Time Frame: 40 minutes
Validate the pulse oximetry measurements obtained using the SKIIN Textile in children with and without heart disease compared to the measurements obtained by the Nonin, WristOx2TM, Model 3150, Wrist-worn Pulse Oximeter
40 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To extract and analyze temperature data obtained using the SKIIN Textile in children with
Time Frame: 40 minutes
To extract and analyze temperature data obtained using the SKIIN Textile in children with
40 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Aamir Jeewa, MD, The Hospital for Sick Children

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2021

Primary Completion (Actual)

April 1, 2022

Study Completion (Actual)

March 30, 2023

Study Registration Dates

First Submitted

November 29, 2019

First Submitted That Met QC Criteria

March 9, 2020

First Posted (Actual)

March 12, 2020

Study Record Updates

Last Update Posted (Actual)

July 7, 2023

Last Update Submitted That Met QC Criteria

July 6, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CTO 1891

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on Myant SKIIN Device

Subscribe